This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/drugbank/drug/DB07117/identifier/chemspider/
n8http://bio2rdf.org/drugbank:
n11http://linked.opendata.cz/resource/drugbank/drug/DB07117/identifier/pdb/
admshttp://www.w3.org/ns/adms#
n13http://linked.opendata.cz/resource/drugbank/drug/DB07117/identifier/pubchem-compound/
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n14http://linked.opendata.cz/resource/drugbank/drug/DB07117/identifier/pubchem-substance/
n10http://linked.opendata.cz/resource/drugbank/drug/DB07117/identifier/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB07117
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB07117 n8:DB07117
dcterms:title
5-(4-PHENOXYPHENYL)-5-(4-PYRIMIDIN-2-YLPIPERAZIN-1-YL)PYRIMIDINE-2,4,6(2H,3H)-TRIONE
adms:identifier
n10:DB07117 n11:4MR n12:8248391 n13:10072851 n14:99443588
n3:IUPAC-Name
n4:271B4B89-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4B8F-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4B8E-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4B8B-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4B8C-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4B8D-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4B87-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4B85-363D-11E5-9242-09173F13E4C5 n4:271B4B88-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4B86-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4B95-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4B96-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4B90-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4B91-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4B93-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4B92-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4B94-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4B9B-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4B9D-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4B9E-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4B9A-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4B99-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4B9C-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4B8A-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4B97-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4B98-363D-11E5-9242-09173F13E4C5